FPH Share Price Performance
NZ$0
-34.62 (-100.00%)
Price NZ$0
Fair ValueNZ$40.81
Share Pricen/a
Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shareholders Might Be Looking For Exit
Feb 15
Fisher & Paykel Healthcare Corporation Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 37 Fair Values set on narratives written by author
FPH Community Narratives
AN
Fair Value NZ$40.81 0.5% overvalued intrinsic discount
Analysts Hold Price Target for Fisher and Paykel Healthcare as Valuation Inputs Remain Stable
0users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
AN
Fair Value NZ$46 10.9% undervalued intrinsic discount
Respiratory Therapy Adoption Will Drive Stronger Margins And Support Long Term Upside
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value NZ$29.31 39.9% overvalued intrinsic discount
Tariff Pressures And Slowing Hospital Adoption Will Constrain Long-Term Earnings Trajectory
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Analysts Hold Price Target for Fisher and Paykel Healthcare as Valuation Inputs Remain Stable
Key Takeaways Product innovation, expansion in hospital and homecare, and operational efficiency are strengthening revenue growth, margin improvement, and pricing power. Global demographic trends and rising healthcare investment are broadening market opportunities and diversifying recurring revenue streams.Read more
300
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
AN
NZ$40.81
0.5% overvalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
11.71% p.a.
Profit Margin
22.51%
Future PE
44.77x
Price in 2029
NZ$51.28
Respiratory Therapy Adoption Will Drive Stronger Margins And Support Long Term Upside
Catalysts About Fisher & Paykel Healthcare Fisher & Paykel Healthcare designs, manufactures and sells respiratory care and home care medical devices and consumables used in hospitals and patient homes globally. What are the underlying business or industry changes driving this perspective?Read more
33
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
NZ$46
10.9% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
12.81% p.a.
Profit Margin
23.99%
Future PE
45.79x
Price in 2029
NZ$57.55
Tariff Pressures And Slowing Hospital Adoption Will Constrain Long-Term Earnings Trajectory
Catalysts About Fisher & Paykel Healthcare Fisher & Paykel Healthcare designs, manufactures and markets respiratory care and home care medical devices and consumables used in hospitals and at home. What are the underlying business or industry changes driving this perspective?Read more
31
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
NZ$29.31
39.9% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
10.03% p.a.
Profit Margin
21.67%
Future PE
34.8x
Price in 2028
NZ$36.67
Trending Discussion
Recently Updated Narratives
AN
FPH: Improved Guidance And Rating Upgrade Will Support Fairly Valued Outlook
Fair Value: NZ$40.81 0.5% overvalued intrinsic discount
20 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Respiratory Therapy Adoption Will Drive Stronger Margins And Support Long Term Upside
Fair Value: NZ$46 10.9% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Tariff Pressures And Slowing Hospital Adoption Will Constrain Long-Term Earnings Trajectory
Fair Value: NZ$29.31 39.9% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Fisher & Paykel Healthcare Corporation Limited Key Details
About FPH
- Founded
- 1934
- Employees
- 7412
- CEO
- WebsiteView website
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
